Literature DB >> 11479311

Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase.

T Saric1, J Beninga, C I Graef, T N Akopian, K L Rock, A L Goldberg.   

Abstract

Nearly all peptides generated by proteasomes during protein degradation are digested rapidly to amino acids, but a few proteasomal products escape this fate and are presented to the immune system on cell surface major histocompatibility complex class I molecules. To test whether these antigenic peptides may be inherently resistant to cytosolic peptidases, six different antigenic peptides were incubated with HeLa cell extracts. All six were degraded rapidly by a process involving o-phenanthroline-sensitive metallopeptidases. One antigenic peptide, FAPGNYPAL, was rapidly destroyed in the extracts by a bestatin-sensitive exopeptidase, apparently by the puromycin-sensitive aminopeptidase. The disappearance of the other five was reduced 30-90% by a specific inhibitor of the cytosolic endopeptidase, thimet oligopeptidase (TOP) (EC ), whose physiological function(s) have been unclear and controversial. All these peptides were sensitive to pure recombinant TOP. Furthermore, upon fractionation of the extracts, the major peptidase peak that degraded the ovalbumin-derived epitope, SIINFEKL, co-purified with TOP. In the extracts, TOP also catalyzed rapid degradation of N-extended variants of SIINFEKL and of other antigenic peptides, which in vivo can serve as precursors of these major histocompatibility complex-presented epitopes. This enzyme (unlike cell proteins that promote production of antigenic peptides) is not regulated by interferon-gamma. TOP seems to be primarily responsible for the rapid breakdown of antigenic peptides in cytosolic extracts, and our related studies (A. X. Y. Mo, K. Lemerise, W. Zeng, Y. Shen, C. R. Abraham, A. L. Goldberg, and K. L. Rock, submitted for publication) indicate that TOP by destroying such peptides limits antigen presentation in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11479311     DOI: 10.1074/jbc.M105517200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Mapping sequence differences between thimet oligopeptidase and neurolysin implicates key residues in substrate recognition.

Authors:  Kallol Ray; Christina S Hines; David W Rodgers
Journal:  Protein Sci       Date:  2002-09       Impact factor: 6.725

2.  Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire.

Authors:  Nicholas J Steers; Jeffrey R Currier; Gustavo H Kijak; Robert C di Targiani; Ashima Saxena; Mary A Marovich; Jerome H Kim; Nelson L Michael; Carl R Alving; Mangala Rao
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

3.  Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection.

Authors:  Alexey Popov; Zeinab Abdullah; Claudia Wickenhauser; Tomo Saric; Julia Driesen; Franz-Georg Hanisch; Eugen Domann; Emma Lloyd Raven; Oliver Dehus; Corinna Hermann; Daniela Eggle; Svenja Debey; Trinad Chakraborty; Martin Krönke; Olaf Utermöhlen; Joachim L Schultze
Journal:  J Clin Invest       Date:  2006-11-16       Impact factor: 14.808

4.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

5.  Intracellular peptides as natural regulators of cell signaling.

Authors:  Fernanda M Cunha; Denise A Berti; Zulma S Ferreira; Clécio F Klitzke; Regina P Markus; Emer S Ferro
Journal:  J Biol Chem       Date:  2008-07-10       Impact factor: 5.157

6.  Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape.

Authors:  Estibaliz Lazaro; Carl Kadie; Pamela Stamegna; Shao Chong Zhang; Pauline Gourdain; Nicole Y Lai; Mei Zhang; Sergio A Martinez; David Heckerman; Sylvie Le Gall
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

7.  The cytoplasmic domain of rhesus cytomegalovirus Rh178 interrupts translation of major histocompatibility class I leader peptide-containing proteins prior to translocation.

Authors:  Rebecca Richards; Isabel Scholz; Colin Powers; William R Skach; Klaus Früh
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

8.  Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Authors:  Jaba Gamrekelashvili; Tamar Kapanadze; Miaojun Han; Josef Wissing; Chi Ma; Lothar Jaensch; Michael P Manns; Todd Armstrong; Elizabeth Jaffee; Ayla O White; Deborah E Citrin; Firouzeh Korangy; Tim F Greten
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

9.  Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy.

Authors:  Fiona M Menzies; Raphael Hourez; Sara Imarisio; Marcel Raspe; Oana Sadiq; Dhia Chandraratna; Cahir O'Kane; Kenneth L Rock; Eric Reits; Alfred L Goldberg; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2010-09-09       Impact factor: 6.150

10.  Analysis of intracellular substrates and products of thimet oligopeptidase in human embryonic kidney 293 cells.

Authors:  Denise A Berti; Cain Morano; Lilian C Russo; Leandro M Castro; Fernanda M Cunha; Xin Zhang; Juan Sironi; Clécio F Klitzke; Emer S Ferro; Lloyd D Fricker
Journal:  J Biol Chem       Date:  2009-03-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.